| URL | https://www.npr.org/2022/01/02/1069784223/rapid-te |
| Source | https://www.npr.org |
| Date Published | 01/02/2022 |
| Author Name | Adrian Florido |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | InBios |
| Parent company | InBios |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Seattle |
| State(s) reshored to: | WA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | COVID-19 at-home rapid tests |